Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Adenoma × Drug Evaluation × Clear all

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Conditions

Leukemia, Myeloid, Acute 3 Breast Neoplasms 3 Lymphoma, Non-Hodgkin 2 Colorectal Neoplasms 2 Carcinoma, Basal Cell 2 Basal Cell Nevus Syndrome 2 Upper Tract Urothelial Carcinomas 1 Thrombocythemia, Essential 1 Solid Tumors 1 Serous Ovarian Cancer 1 Recurrence 1 Postmenopausal Women With ER+ HER2- Primary Breast Cancer 1 Polycythemia Vera 1 Lymphedema 1 Liver Neoplasms 1 Leukemia 1 Immunoglobulin Light-chain Amyloidosis 1 Hypogonadism 1 Glioma 1 Fatigue Syndrome, Chronic 1 Fallopian Tube Neoplasms 1 Eunuchism 1 Carcinoma, Ovarian Epithelial 1 Breast Diseases 1 Amyloidosis 1 Adenoma 1

Interventions

Colonoscopy 16 Water 3 Aspirin 3 Ursodeoxycholic Acid 2 Sunitinib 2 Occult Blood 2 Narrow Band Imaging 2 Folic Acid 2 Endoscopic Mucosal Resection 2 Calcium Carbonate 2 pegvisomant 1 gadolinium ethoxybenzyl DTPA 1 defactinib 1 Polyethylene Glycols 1 Octreotide 1 Methods 1 Mesalamine 1 Mass Screening 1 Injections 1 Indocyanine Green 1 Gastroscopy 1 Endoscopy 1 Early Detection of Cancer 1 Drug Evaluation 1 Diet, Fat-Restricted 1 Diagnostic Tests, Routine 1 Cholecystectomy 1 Cholecalciferol 1 Celecoxib 1 Calcitriol 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT02032784 2020-07-16

Prophylactic Octreotide to Prevent Post Duodenal EMR and Ampullectomy Bleeding

AdventHealth

Phase 4 Terminated

Adenoma

Data powered by HemOnc (CC BY 4.0) Colophon ⚡